Chat GPT-4 significantly surpasses GPT-3.5 in drug information queries

Abstract

Get full access to this article

View all access options for this article.

References

Lee

Bubeck

Petro

. Benefits, limits, and risks of GPT-4 as an AI chatbot for medicine. N Engl J Med 2023; 388: 1233–1239.

Patel

Lam

. ChatGPT: The future of discharge summaries? Lancet Digit Health 2023; 5: e107–e108.

Grünebaum

Chervenak

Pollet

, et al. The exciting potential for ChatGPT in obstetrics and gynecology. Am J Obstet Gynecol 2023; 228: 696–705.

Sarraju

Bruemmer

Van Iterson

, et al. Appropriateness of cardiovascular disease prevention recommendations obtained from a popular online chat-based artificial intelligence model. JAMA 2023; 329: 842–844.

Sng

GGR

Tung

JYM

Lim

DYZ

, et al.

Potential and pitfalls of ChatGPT and natural-language artificial intelligence models for diabetes education.

Diabetes Care 2023: 46: e103–e105.

Snoswell

Kelly

, et al.

Artificial intelligence: augmenting telehealth with large language models

[published online ahead of print, 2023 Apr 11]. J Telemed Telecare 2023: 1357633X231169055.

Haupt

Marks

. AI-Generated medical advice-GPT and beyond. JAMA 2023; 329: 1349–1350.